Invesco Ltd. - TANDEM DIABETES CARE INC ownership

TANDEM DIABETES CARE INC's ticker is TNDM and the CUSIP is 875372203. A total of 291 filers reported holding TANDEM DIABETES CARE INC in Q1 2024. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of TANDEM DIABETES CARE INC
ValueSharesWeighting
Q2 2024$8,199,055
-8.5%
203,501
-19.5%
0.00%0.0%
Q1 2024$8,956,321
+23.2%
252,932
+2.9%
0.00%0.0%
Q4 2023$7,267,422
+27.8%
245,687
-10.3%
0.00%0.0%
Q3 2023$5,687,532
-21.8%
273,834
-7.6%
0.00%0.0%
Q2 2023$7,272,233
-39.9%
296,342
-0.5%
0.00%
-33.3%
Q1 2023$12,099,343
+168.2%
297,940
+196.9%
0.00%
+200.0%
Q4 2022$4,510,732
-92.3%
100,350
-91.9%
0.00%
-94.7%
Q3 2022$58,950,000
-54.0%
1,231,986
-43.1%
0.02%
-51.3%
Q2 2022$128,194,000
-47.0%
2,165,811
+4.1%
0.04%
-37.1%
Q1 2022$241,904,000
-17.3%
2,080,173
+7.1%
0.06%
-11.4%
Q4 2021$292,456,000
+41.0%
1,942,971
+11.8%
0.07%
+32.1%
Q3 2021$207,425,000
+32.8%
1,737,518
+8.4%
0.05%
+39.5%
Q2 2021$156,147,000
-0.1%
1,603,154
-9.5%
0.04%
-9.5%
Q1 2021$156,277,000
-6.8%
1,770,851
+1.0%
0.04%
-14.3%
Q4 2020$167,696,000
-8.3%
1,752,679
+8.8%
0.05%
-21.0%
Q3 2020$182,882,000
+15.3%
1,611,306
+0.5%
0.06%
+8.8%
Q2 2020$158,650,000
+48.2%
1,603,825
-3.6%
0.06%
+26.7%
Q1 2020$107,059,000
+127.4%
1,663,692
+110.6%
0.04%
+200.0%
Q4 2019$47,087,000
+147.1%
789,912
+144.5%
0.02%
+200.0%
Q3 2019$19,055,000
+198.9%
323,073
+227.0%
0.01%
+150.0%
Q2 2019$6,374,000
-28.7%
98,796
-29.8%
0.00%
-33.3%
Q1 2019$8,935,000
+188.5%
140,704
+72.5%
0.00%
+200.0%
Q4 2018$3,097,000
+100.8%
81,570
+126.7%
0.00%
Q3 2018$1,542,000
+97.9%
35,988
+1.7%
0.00%
Q2 2018$779,00035,3720.00%
Other shareholders
TANDEM DIABETES CARE INC shareholders Q1 2024
NameSharesValueWeighting ↓
Consonance Capital Management LP 1,022,257$60,293,0005.97%
APIS CAPITAL ADVISORS, LLC 50,000$2,949,0004.62%
SECTORAL ASSET MANAGEMENT INC 432,815$25,527,0004.40%
CROWN ADVISORS MANAGEMENT, INC. 75,000$4,424,0002.96%
OBERWEIS ASSET MANAGEMENT INC/ 199,410$11,761,0002.66%
Asymmetry Capital Management, L.P. 18,995$1,120,0002.40%
Redmile Group, LLC 1,160,401$68,440,0002.29%
FRIESS ASSOCIATES LLC 501,985$29,607,0002.29%
Atika Capital Management LLC 142,000$8,375,0001.76%
Chicago Capital, LLC 433,083$25,543,0001.71%
View complete list of TANDEM DIABETES CARE INC shareholders